R. Fruscio

Latest

• A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers
• Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis
• Genome-wide copy-number alterations in circulating tumor DNA as a novel biomarker for patients with high-grade serous ovarian cancer
• Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies
• Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer
• Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3
• Transcriptional characterization of stage i epithelial ovarian cancer: A multicentric study
• LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study
• A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment
• Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study
• MicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
• MiRNA landscape in stage i epithelial ovarian cancer defines the histotype specificities
• Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
• Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: A retrospective study of two independent tumour tissue collections